DAB2IP and hepatocellular carcinoma: Aside from promoting the proliferation, migration, and invasion abilities of HCC cells by silencing the expression of the target gene DAB2IP, we assumed that tRF‐34‐P4R8YP9LON4VHM could accelerate HUVECs tube formation ability by secreting growth factors or pro‐angiogenic products from HCC cells into the extracellular environment.